NCI federally funded research and development center (FFRDC) contract.
Ended Awarded Last action
- Contract number
- 75N91021F00002
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,289,947
Award facts
- Opportunity
-
- NCI210041 Solicitation number
- Contract value 100% obligated
- $6,289,947.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$81,137 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $111,099 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,935,987 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,323,998 |
Show all 11
About this award
This is a federal contract award to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to serve as the National Cancer Institute's (NCI) Federally Funded Research and Development Center (FFRDC) contractor. The $6,289,947.00 cost-plus-fixed-fee contract, awarded on February 9, 2021, has a period of performance through November 13, 2025. Leidos Biomedical Research Inc. will provide a comprehensive range of biomedical research and facilities support services to the NCI, including operations and maintenance, research and development, clinical trials management, manufacturing, and specialized laboratory testing. This contract is not set aside for any particular business category. As the NCI's FFRDC contractor, Leidos Biomedical Research Inc. will support the institute's various research programs, including efforts related to cancer, infectious diseases, and therapeutics development.
Quick answers
Who was awarded contract 75N91021F00002?
75N91021F00002 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on February 9, 2021.
How much is contract 75N91021F00002 worth?
The government has obligated $6,289,947 on 75N91021F00002.
Is contract 75N91021F00002 an order under another contract?
Yes. 75N91021F00002 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00002 competed?
The extent of competition for 75N91021F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award